BioMarin
1 known investors
Find your way into BioMarin
Sign up to see every warm intro you have to BioMarin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BioMarin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.
Investors · 1
In the news
Frequently asked questions
- What does BioMarin do?
- BioMarin is a biotechnology company that develops medicines derived from genetic discoveries to treat serious and rare diseases. Founded in 1997, it markets nine commercial therapies and maintains a clinical and preclinical drug development pipeline.
- Who are BioMarin's investors?
- BioMarin's investors include Ridgeback Capital.